Ghent University Academic Bibliography

Your filters: cql: keyword exact "lipid nanoparticle"

Add to list
- Journal Article
- A1
- open access
A f entanyl hapten-displaying lipid nanoparticle vaccine that non-covalently encapsulates a TLR7/8 agonist and T-helper epitope induces protective anti-fentanyl immunity

Zifu Zhong (UGent) , Marie Deventer (UGent) , Yong Chen (UGent) , Stijn Vanhee (UGent) , Inés Lammens (UGent) , Kim Deswarte (UGent) , Yi Huang (UGent) , Tingting Ye (UGent) , Haixiu Wang (UGent) , Lutz Nuhn, et al.

(2025) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 64(7).
Add to list
- Journal Article
- A1
- open access
Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria

Sofie Meulewaeter (UGent) , Ilke Aernout (UGent) , Joke Deprez (UGent) , Yanou Engelen (UGent) , Margo De Velder (UGent) , Lorenzo Franceschini, Karine Breckpot, Serge Van Calenbergh (UGent) , Caroline Asselman (UGent) , Katie Boucher (UGent) , et al.

(2024) JOURNAL OF CONTROLLED RELEASE. 370. p.379-391
Add to list
- Journal Article
- A1
- open access
mTOR inhibition enhances delivery and activity of antisense oligonucleotides in uveal melanoma cells

Shanna Dewaele, Louis Delhaye (UGent) , Boel De Paepe (UGent) , Bram Bogaert, Ramiro Martinez (UGent) , Jasper Anckaert (UGent) , Nurten Yigit (UGent) , Justine Nuytens (UGent) , Rudy Van Coster (UGent) , Sven Eyckerman (UGent) , et al.

(2023) NUCLEIC ACID THERAPEUTICS. 33(4). p.248-264
Add to list
- Journal Article
- A1
- open access
Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics

Pieter Vervaeke (UGent) , S.E. Borgos, Niek Sanders (UGent) and F. Combes

(2022) ADVANCED DRUG DELIVERY REVIEWS. 184.
Add to list
- Journal Article
- A1
- open access
Three decades of messenger RNA vaccine development

Rein Verbeke (UGent) , Ine Lentacker (UGent) , Stefaan De Smedt (UGent) and Heleen Dewitte (UGent)

(2019) NANO TODAY. 28.
Add to list
- PhD Thesis
- open access
Design of messenger RNA lipid nanoparticles for cancer immunotherapy

Rein Verbeke (UGent)

(2019)
Add to list
Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy : restoring the immunogenicity of immunosilent mRNA

Rein Verbeke (UGent) , Ine Lentacker (UGent) , Laura Wayteck (UGent) , Karine Breckpot, Mieke Van Bockstal (UGent) , Benedicte Descamps (UGent) , Christian Vanhove (UGent) , Stefaan De Smedt (UGent) and Heleen Dewitte (UGent)

(2017) JOURNAL OF CONTROLLED RELEASE. 266. p.287-300

Academic Bibliography

A f entanyl hapten-displaying lipid nanoparticle vaccine that non-covalently encapsulates a TLR7/8 agonist and T-helper epitope induces protective anti-fentanyl immunity

Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria

mTOR inhibition enhances delivery and activity of antisense oligonucleotides in uveal melanoma cells

Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics

Three decades of messenger RNA vaccine development

Design of messenger RNA lipid nanoparticles for cancer immunotherapy

Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy : restoring the immunogenicity of immunosilent mRNA

Contents

Support

Contact